|
|
|
Summary
of 1996 CPCRA Posters and Presentations
| 3rd Conference on Retroviruses and Opportunistic Infections, January 28-February 1, 1996, Washington, DC |
Saravolatz l, Collins G, Hodges J, Winslow D. A Randomized, Comparative Trial of ZDV versus ZDV plus ddI versus ZDV plus ddC in Persons with CD4 Cell Counts of <200/mm3. Oral. CPCRA 007, NuCombo. Abstract no. LB4.
abstract
Benson C, Cohn D, Williams P. A Phase III Prospective, Randomized, Double-Blind Study of the Safety and Efficacy of Clarithromycin (CLA) vs. Rifabutin (RBT) vs. CLA-RBT for Prevention of Mycobacterium avium Complex (MAC) Disease in HIV Patients with CD4 Count 100 Cells/mL. Poster. CPCRA 009/ACTG 196, MAC Prophylaxis. Abstract no. 205.
abstract
| 5th European Conference on HIV Infection, January 15,-20, 1996 |
Torres R, Neaton J, Wentworth D, Barr M, Abrams D, Sherer R, Ward T, Sampson J. Acyclovir and Survival in an Observational Cohort Enrolled by the Community Programs for Clinical Research on AIDS (CPCRA). Poster.
abstract
| 17th Annual Meeting, Society for Clinical Trials, May 5-7, 1996 |
Harrison M, DuChene A. Automated Edit System From Data Entry to Site Notification. Printed.
abstract
Collins G, Neaton J, Wentworth D. Observational Data Analyses Within a Clinical Trials Network: The CPCRA Cross Study Database. Printed
abstract
| XI International Conference on AIDS, July 7-12, 1996, Vancouver, BC, Canada |
Cobb M, Desai J, Brown Jr LS, Zannikos P, Trapnell C, Rainey P. The Effect of Fluconazole on the Clinical Pharmacokinetics of Methadone. Poster. CPCRA 003 ODB.
abstract
Saravolatz LD, Collins G, Hodges JS, Winslow D, Pettinelli C. A Randomized, Comparative Trial of ZDV Versus ZDV Plus ddI Versus ZDV Plus ddC in Persons With CD4 Cell Counts of <200/mm3. Oral. CPCRA 007 NuCombo.
abstract
Gibert C, Wheeler D, Launer C, Muurahainen N, Raghavan S, Madans M, Higgs E, Elion R, Bartsch G. Issues in the Design and Implementation of Large Scale Community Based Clinical Trials in Nutrition and AIDS. Poster.
abstract
Caldwell R, Cox LE, Morse EV, Pieper M, Turner M, Vallier W, Simon PM, Launer C. HIV/AIDS Community Based Clinical Trials Achieve Low Lost to Followup Rates. Poster.
abstract
El Sadr W, Perlman D, Matts J, Nelson E, Cohn D, Telzak E, Chirgwin K, Salomon N, Olibrice M, Hafner R. Outcome of an Induction Regimen for the Treatment of HIV related Tuberculosis (TB): Evaluation of the Addition of a Quinolone. Poster. CPCRA 019 TB Treatment.
abstract
Fisher E, Brosgart C, Hillman D, Louis T, Craig C, El-Sadr W. Predictive Factors for Developing Cytomegalovirus Disease Among AIDS Patients in a Trial of Oral Ganciclovir Prophylaxis. Poster. CPCRA 023 CMV Prophylaxis.
abstract
Hogan C, Hodges JS, Mugglin A, Peterson PM, Abrams DI, Saravolatz LD. The Perils of Visit Driven Endpoints in Antiretroviral Trials. Oral.
abstract
Wheeler D, Muurahainen N, Elion R, Launer C, Gibert C, Bartsch G. Change in Body Weight (WT) as a Predictor of Death and Opportunistic Complications (OC) in HIV by History of Prior OC. Poster.
abstract
Schuman P, Vazquez J, Sobel JD, Goldman A, Peng G, Capps L. A Randomized Trial Comparing Fluconazole with Placebo for Prophylaxis of Mucosal Candidiasis in Women with HIV Infection. Oral. CPCRA 010 Women's Fungal.
abstract
Mooney K, Lambert J, Fakhry R, Deisinger G, Sippel L, McMillen L, Vallier W, MacArthur R.
Improved Data Quality as a Result of a Research Nurse Designed Quality Assurance Program in an Urban Setting. Poster.
abstract
Neaton J, Hogan C, Chaloner K, Forsgren J, Hare D, Larntz K, Louis T, Roane R, Wentworth D.
CPCRA Seminars: A Model for Involvement of Patients in Community Based Clinical Research. Poster.
abstract
Wentworth D, Neaton J. Time Trends in Opportunistic Events Preceding Death in a Large Cohort of HIV Positive Patients. Poster.
abstract
Cohn D, Fisher E, Franchino B, Hodges JS, Chesnut J, Child C, Gibert C, El Sadr W, Hafner R, Ropka m, Heifets l, Clotfelter J, Munroe D, Caldwell R, Canaday K, Horsburgh CR. Comparison of Two Doses of Clarithromycin in a Randomized Trial of Four 3 Drug Regimens for Treatment of Disseminated Mycobacterium Avium Complex Disease in AIDS: Excess Mortality Associated with High Dose Clarithromycin. Poster. CPCRA 027 MAC Treatment.
abstract
Cohn D, Benson CA, Williams P, Nevin T, Korvick j, Hafner R, Bourland D, Kopek E, Becker S, Hojczyk P, Timmons P, Child C. A Prospective, Randomized, Double Blind, Comparative Study of the Safety and Efficacy of Clarithromycin (CLA) vs. Rifabutin (RBT) vs. the Combination for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia or Disseminated MAC Disease (DMAC) in HIV-Infected Patients (Pts) With CD4 Counts 100 Cells/mm3. Oral. CPCRA 009 MAC Prophylaxis.
abstract
Fuentes L, El-Sadr W, Julius S, Hardy M, Guity C, Messeri P. Development of an Active Community Advisory Board in the Minotiry Inner City Community of Harlem, U.S.A. Poster.
abstract
Brosgart C, Craig C, Hillman D, Louis t, Alston b, Fisher E, El Sadr W. Final Results From a Randomized, Placebo Controlled Trial of the Safety and Efficacy of Oral Ganciclovir for Prophylaxis of CMV Retinal and Gastrointestinal Mucosal Disease in HIV infected Individuals with Severe Immunosuppression. Oral. CPCRA 023 CMV Prophylaxis.
abstract
Pablovich S, Walker J, Besch CL. Reasons Patients Refuse to Participate in HIV Clinical Trials: Experience at One Clinical Trials Unit. Poster
abstract
Mayers D, Saravolatz LD, Winslow D, Jagodzinski J, Collins G, Hodges JS, Pettinelli C, Weislow O, Stein D. Viral Burden Measurements in CPCRA 007. Oral. CPCRA 007 NuCombo.
abstract
| 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 15-18, 1996, New Orleans, LA |
El Sadr W, Matts J, Hillman D, Brosgart C, Neaton J. Bacterial Pneumonia: A Significant Risk Among a Subgroup of HIV Infected Patients. Poster.
abstract
Thompson MA, Howard S, Nelson e, Hodges js, Perez G, Chernoff D, Mayers D, Deyton LR.
Correlation and distribution of baseline plasma HIV RNA and CD4+ cell counts in the first 1,101 patients in Community Programs for Clinical Research on AIDS (CPCRA) protocol 036. Poster. CPCRA 036 HIV RNA.
abstract
Donovan R, Mayers D, Bush C, Jagodzinski J, Weislow O, Baxa D, Winslow D, Collins G, Hodges JS, Reves R, Saravolatz LD. Prediction of disease progression in CPCRA 007: The role of unintegrated HIV DNA (UDNA) and HIV RNA. Poster. CPCRA 007 NuCombo.
abstract
Gordin F, Matts J, Miller C, Brown Jr LS, El‑Sadr W. A Prospective, Double‑blind, Placebo‑Controlled Trial of Isoniazid (INH) for Prevention of Tuberculosis (TB) in Anergic HIV‑Infected Patients (pts) at High Risk for TB. Oral. CPCRA 005 TB/Anergic.
abstract
Vazquez J, Steele-Moore L, Schuman P, Peng G, Holloway W, Sobel J, Furness K. Antifungal Susceptibility Among Candida Species Recovered From HIV-Positive Women Receiving Fluconazole Prophylaxis. Poster.
abstract
| 34th Infectious Diseases Society of America Annual Meeting, September 19-21, 1996, New Orleans, LA |
El-Sadr W, Perlman D, Nelson E, Matts J. High Mortality Rate Associated With HIV-Related Tuberculosis In an Observational Study. Poster.
abstract
| 19th Annual Conference of the Association of Nurses in AIDS Care (ANAC), October 21-24, 1996, Chicago, IL |
Dawson K, Chesnut J, Lanier L, Bray J. Protocol‑Specific Educational Materials for Patients Participating in HIV/AIDS Clinical Research. Poster
abstract
| 124th American Public Health Association (APHA) Annual Meeting, November 17-19, 1996, New York, NY |
Klein M, Hardy M, Minniefield C, Capps L, Guity C, Fuentes L, El SadrW. Focus on Primary Care as a Strategy for Ensuring Adherence With Research Studies. Poster.
abstract |
|
